---
figid: PMC6329627__BPH-176-337-g003
figtitle: Molecular mechanisms for PGE2‐cytokine crosstalk in facilitation of adaptive
  Th1 and Th17 cell responses
organisms:
- Mus musculus
- Rattus norvegicus
- Mycobacterium tuberculosis
- Helicobacter hepaticus
- Homo sapiens
- clinical samples
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Drosophila melanogaster
pmcid: PMC6329627
filename: BPH-176-337-g003.jpg
figlink: /pmc/articles/PMC6329627/figure/bph14530-fig-0003/
number: F3
caption: Molecular mechanisms for PGE2‐cytokine crosstalk in facilitation of adaptive
  Th1 and Th17 cell responses. (A) PGE2 through EP2/EP4 receptors activates the cAMP‐PKA‐CREB/CRTC2
  pathway that in turn drives the expression of IL‐12β2 and IFN‐γ 1 receptors (R)
  and amplifies cytokine signalling, leading to facilitation of Th1 cell differentiation.
  Additionally, activation of PI3K by strengthened CD28 costimulation and that by
  EP2/EP4 receptors further supports Th1 cell differentiation by antagonizing cAMP/PKA‐mediated
  suppression of TCR activation. (B) IL‐23 induces COX‐2 expression and low levels
  of PGE2 production by activated Th17 cells. T‐cell‐intrinsic PGE2 then acts back
  on Th17 cells for the induction of IL‐23 receptor (and possibly also IL‐1 receptor)
  through the positive feedback IL‐23‐PGE2‐EP2/EP4‐cAMP‐PKA‐STAT3/CREB/NF‐κB‐IL‐23
  receptor loop, leading to the generation of pathogenic Th17 cells by synergistic
  actions with IL‐23 and/or IL‐1. CREB and CRTC2 can also directly drive IL‐17A gene
  expression by binding to its promoter. (C) Activation of NF‐κB induced by TLR or
  CD40 engagement on DCs induces the early phase of IL‐23 p19 gene expression. NF‐κB
  also induces DCs to express COX2 and PGE2, which then further amplifies NF‐κB signalling
  for the IL‐23 p19 expression through the EP2/EP4‐cAMP‐PKA‐CREB pathways. PGE2 can
  also induce IL‐23 p19 expression through cAMP‐Epac pathway‐activated C/EBPβ.
papertitle: Prostaglandin‐cytokine crosstalk in chronic inflammation.
reftext: Chengcan Yao, et al. Br J Pharmacol. 2019 Feb;176(3):337-354.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9653397
figid_alias: PMC6329627__F3
figtype: Figure
redirect_from: /figures/PMC6329627__F3
ndex: a4535972-dec9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6329627__BPH-176-337-g003.html
  '@type': Dataset
  description: Molecular mechanisms for PGE2‐cytokine crosstalk in facilitation of
    adaptive Th1 and Th17 cell responses. (A) PGE2 through EP2/EP4 receptors activates
    the cAMP‐PKA‐CREB/CRTC2 pathway that in turn drives the expression of IL‐12β2
    and IFN‐γ 1 receptors (R) and amplifies cytokine signalling, leading to facilitation
    of Th1 cell differentiation. Additionally, activation of PI3K by strengthened
    CD28 costimulation and that by EP2/EP4 receptors further supports Th1 cell differentiation
    by antagonizing cAMP/PKA‐mediated suppression of TCR activation. (B) IL‐23 induces
    COX‐2 expression and low levels of PGE2 production by activated Th17 cells. T‐cell‐intrinsic
    PGE2 then acts back on Th17 cells for the induction of IL‐23 receptor (and possibly
    also IL‐1 receptor) through the positive feedback IL‐23‐PGE2‐EP2/EP4‐cAMP‐PKA‐STAT3/CREB/NF‐κB‐IL‐23
    receptor loop, leading to the generation of pathogenic Th17 cells by synergistic
    actions with IL‐23 and/or IL‐1. CREB and CRTC2 can also directly drive IL‐17A
    gene expression by binding to its promoter. (C) Activation of NF‐κB induced by
    TLR or CD40 engagement on DCs induces the early phase of IL‐23 p19 gene expression.
    NF‐κB also induces DCs to express COX2 and PGE2, which then further amplifies
    NF‐κB signalling for the IL‐23 p19 expression through the EP2/EP4‐cAMP‐PKA‐CREB
    pathways. PGE2 can also induce IL‐23 p19 expression through cAMP‐Epac pathway‐activated
    C/EBPβ.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NELFCD
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - CD247
  - CD3D
  - CD3E
  - CD3G
  - CD28
  - IL37
  - IL23A
  - IRF6
  - CD40LG
  - APP
  - AAAS
  - AAA1
  - PTGER2
  - SPAG11B
  - CD40
  - TERC
  - TECR
  - PTGER4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTGS2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CRTC2
  - IL12RB2
  - STAT3
  - IL2
  - IL17A
  - NFKB1
  - CEBPB
  - CDKN2A
  - CDKN2D
  - F9
  - REG1A
  - H3P13
  - IL1R1
  - IL23R
  - IL12A
  - IL12B
  - IL1B
  - LARGE1
  - RAPGEF3
  - RAPGEF4
  - Cd28
  - Cd40lg
  - Ptger2
  - Cd40
  - Ptger4
  - Pik3cg
  - Ptgs2
  - Crtc2
  - Il12rb2
  - Stat3
  - Il2
  - Il17a
  - Nfkb1
  - Il23r
  - Il12b
  - Large1
  - Csf2
  - Rapgef3
  - Hand1
  - Nelfcd
  - Trav6-3
  - Cd3e
  - Cd247
  - D9Mgc45e
  - Il23a
  - Tlr4
  - Aaas
  - Dnd1
  - Pik3r1
  - Cebpb
  - Cdkn2d
  - Stmn1
  - Nsg2
  - Il1
  - TH1
  - Tcr
  - tRNA:Lys-TTT-1-1
  - tRNA:Lys-TTT-2-4
  - tRNA:Lys-TTT-2-1
  - tRNA:Lys-TTT-2-2
  - tRNA:Lys-TTT-2-5
  - tRNA:Lys-TTT-2-3
  - ter
  - term
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - COX2
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Pa
  - pe
  - Dif
  - dl
  - Rel
  - caz
  - l(1)20Ca
  - JIL-1
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Epac
  - TCR
  - PGE
---
